... d1–5 and IDA 5 mg/m 2 /d d1–5 as continuous infusion. Since 2003 ATRA (45 mg/m 2 /d d4–6, 15 mg/m 2 /d d7–28) was added in some patients. Results: 154 patients received (A)-AIDA, median age was 71 years. In 40% the AML was secondary, 15.6% had relapsed AML. The complete remission rate was 41%, 7...

...Ivetta Danylesko; Jonathan Canaani; Avichai Shimoni; Joshua Fein; Noga Shem-Tov; Ronit Yerushalmi; Roni Shouval; Arnon Nagler Introduction: Achievement of an initial complete remission (CR) following induction chemotherapy is tightly correlated with survival in acute myeloid leukemia (AML) patients...

... patient who successfully underwent therapy with pixantrone after alloSCT, obtaining a complete remission without any considerable side effects. [email protected] 22 02 2017 26 02 2017 21 4 2017 © 2017 S. Karger AG, Basel 2017 Copyright / Drug Dosage / Disclaimer...

... operating characteristic analysis. Complete remission (CR) after induction chemotherapy was related to the time to clearance of PBB (p < 0.001). Relapse-free survival (RFS; p = 0.003) and overall survival (p < 0.001) were longer in the EBC group. Multivariate analysis demonstrated that the time...

... that ATRA + ATO combination therapy significantly improved the complete remission (CR) rate (RR = 1.09, 95% CI = 1.03-1.16, p = 0.004), decreased the early mortality rate (RR = 0.42, 95% CI = 0.20-0.9, p = 0.03) and relapse rate (RR = 0.17, 95% CI = 0.07-0.42, p < 0.0001), but increased the high risk...

... to in the content or advertisements. Complete remission Non-Hodgkin’s lymphomas Treatment Hemato-Oncology and Hemato-Immunology. Proc. 2nd Int. Conf., Catania 1986 Acta haemat. 78: suppl. l,pp. 157-162(1987...

...) at diagnosis (lymphoblasts, n=6), normal lymphocytes (n=6) and lymphocytes from children with ALL in complete remission (lymphocytes in CR, n= 12). Among all the spots, those which were deeply stained and large were termed ‘major spots’. Their number was 118. Two spots (No. B1 and B2) were characteristic...

...L. Matera; F.G. Giancotti Natural killer (NK) activity was investigated in 16 patients with acute leukemia in complete remission and in 19 normal subjects. Peripheral blood lymphocytes from the great majority of the patients failed to kill the K562 target cell in a short-term chromium release assay...

...C. Castagnola; M. Bonfichi; A. Colombo; P. Bernasconi; C. Bernasconi We describe a patient with acute nonlymphocytic leukemia in whom chromosomal analysis showed a 8,21(q22;q22) translocation and who entered complete remission after one course of chemotherapy. During the post-chemotherapy aplastic...